Neurogene has transitioned into a data-driven, registrational-stage company with NGN-401. Click here to read why NGNE stock ...

What’s the difference between an economic bubble and an economic transformation? I don’t know, but if either pops, a bunch of ...

Discusses Q3 Results With Record Recurring Revenue and Margin Growth November 25, 2025 10:00 AM EST [Audio Gap] $100,000 or 10%. The increases in revenue were the result of higher sales volumes to our ...

On 12 November 2025, Bristol-Myers Squibb conducted a Phase 3 study to Evaluate the Efficacy and Safety of KarXT + KarX-EC ...

By all accounts, the latest financial disclosure by PDD Holdings ($PDD) was nothing short of disastrous. Although the actual ...

Gemma Biotherapeutics ("GEMMABio"), a leading global genetic medicines company, announced that its novel gene therapy for spinal muscular atrophy type 1 (SMA1) is cleared for clinical trial by ANVISA, ...

NCLT Indore initiates corporate insolvency proceedings against a private company for default in repayment of ₹10.44 crore, appointing an IRP and declaring moratorium under ...

Easily one of the strongest names in the market this year, Robinhood (HOOD) has delighted investors with its massive return ...

NCLAT ruled that GST dues of a corporate debtor, once admitted in CIRP, transform into operational debt, allowing assignment to a private creditor. The appeal challenging the debt transfer was ...

(1) The three biopolymers—xanthan gum, guar gum, and carrageenan—can all effectively improve the shear strength characteristics of Guilin red clay. The core mechanism is to form a cementation network ...

Thirty years ago, in 1995, we visited Titan's main factory in Hosur, near Bangalore – since renamed Bengaluru. We were amazed ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.